Shihe Pharmaceutical Group: Preliminary estimate that the company's attributable profit to equity holders will decrease by 45% to 60% year-on-year by 2025.

Shisuo Pharmaceutical Group announced on the Hong Kong Stock Exchange that the preliminary estimate for the company’s attributable profit to equity holders in 2025 will decrease by 45% to 60% year-on-year, with 2024’s profit at HKD 1.061 billion.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)